Literature DB >> 2990345

Biosynthesis rates and content of thymosin beta 4 in cell lines.

E Hannappel, W Leibold.   

Abstract

The content and relative biosynthetic rates of thymosin beta 4 have been determined in 28 different cell lines. The highest content of thymosin beta 4 as well as the highest rate of biosynthesis was observed in Epstein-Barr virus-transformed human B-cell lines. The levels observed in these cells are 1 pg thymosin beta 4 per cell, which is three times higher than that in rat peritoneal macrophages. Thus, these B-cell lines have the highest content of thymosin beta 4 of any cell type yet described. Since all of the Epstein-Barr virus-transformed B-cells described here grow in suspension, it is unlikely that the presence of thymosin beta 4 is related to anchorage in these cells. Thymosin beta 4 is not secreted by viable Epstein-Barr virus-transformed B cells in culture, suggesting some intracellular function of the peptide. These results indicate that these B-cell lines may be suitable for the study of thymosin beta 4 function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990345     DOI: 10.1016/0003-9861(85)90028-1

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  18 in total

1.  Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells.

Authors:  M C Sanders; A L Goldstein; Y L Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  The complete sequences of trout (Salmo gairdneri) thymosin beta 11 and its homologue thymosin beta 12.

Authors:  P P Yialouris; B Coles; O Tsitsiloni; B Schmid; S Howell; A Aitken; W Voelter; A A Haritos
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

3.  Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway.

Authors:  Gabriel Sosne; Ping Qiu; Patricia L Christopherson; Michelle Kurpakus Wheater
Journal:  Exp Eye Res       Date:  2007-01-23       Impact factor: 3.467

4.  Distribution and biological activity ofβ-thymosins.

Authors:  M Mihelić; W Voelter
Journal:  Amino Acids       Date:  1994-02       Impact factor: 3.520

Review 5.  Global treadmilling coordinates actin turnover and controls the size of actin networks.

Authors:  Marie-France Carlier; Shashank Shekhar
Journal:  Nat Rev Mol Cell Biol       Date:  2017-03-01       Impact factor: 94.444

6.  Thymosin β4 in rheumatoid arthritis: Friend or foe.

Authors:  Kyoung Soo Kim; Hyung-In Yang
Journal:  Biomed Rep       Date:  2017-07-25

7.  Use of ProteinChip array surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) to identify thymosin beta-4, a differentially secreted protein from lymphoblastoid cell lines.

Authors:  Deborah L Diamond; Yanni Zhang; Alexander Gaiger; Molly Smithgall; Thomas S Vedvick; Darrick Carter
Journal:  J Am Soc Mass Spectrom       Date:  2003-07       Impact factor: 3.109

8.  Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent.

Authors:  Gabriel Sosne; Ping Qiu; Michelle Kurpakus-Wheater
Journal:  Clin Ophthalmol       Date:  2007-09

9.  Identification and characterization of mRNAs regulated by nerve growth factor in PC12 cells.

Authors:  D G Leonard; E B Ziff; L A Greene
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

Review 10.  The beta-thymosins, small actin-binding peptides widely expressed in the developing and adult cerebellum.

Authors:  Jaime Gómez-Márquez; Ramón Anadón
Journal:  Cerebellum       Date:  2002-04       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.